654-28965-30686
2 vaccinations
4 coded responses
12 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 961 / CA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-02-01
Dose 1 — Moderna
-
2021-03-01
Dose 2 — Moderna
-
2021-03-05
Registered in v-safe
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site rash — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Large bruise (2 inch diameter) at injection site, red itchy rash from mid upper arm wrapping around nicely down to elbowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Fatigue or tirednessFree text: Large 2 inch diameter bruise at injection site persistsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-31
- 2021-04-05
- 2021-04-12
- 2021-05-31
-
2021-08-30
Survey response — 6 months, dose 2MedDRA: Cough, Dysphonia, Fatigue, Headache, Smoke sensitivity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: New onset on 8/28 for two days of headache, cough, fatigue, hoarse voice. We are also in (b)(6) region experiencing heavy fire smoke so hard to know if smoke exposure or illness. Fatigue and hoarse voice have continued to present.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-03-01
Survey response — 12 months, dose 2MedDRA: COVID-19, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID in January, with post COVID muscle aches that are mostly resolved but reoccur if I get run downMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Moderna | |
| 2 | 2021-03-01 | Moderna |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Large bruise (2 inch diameter) at injection site, red itchy rash from mid upper arm wrapping around nicely down to elbow
Systemic reaction (other): Large 2 inch diameter bruise at injection site persists
Release 9 — 6 months, dose 2
Symptoms: New onset on 8/28 for two days of headache, cough, fatigue, hoarse voice. We are also in (b)(6) region experiencing heavy fire smoke so hard to know if smoke exposure or illness. Fatigue and hoarse voice have continued to present.
redacted (b)(6)
Release 11 — 12 months, dose 2
Symptoms: COVID in January, with post COVID muscle aches that are mostly resolved but reoccur if I get run down
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dysphonia | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Smoke sensitivity | ✓ | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release